NASDAQ:GLSI
Greenwich LifeSciences, Inc.
- Stock
Last Close
16.62
26/07 20:00
Market Cap
203.12M
Beta: 3.53
Volume Today
34.03K
Avg: 47.81K
PE Ratio
−13.47
PFCF: −17.98
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 503.93K - | 720.64K 43.00% | 465.91K 35.35% | 110.53K 76.28% | 128.27K 16.05% | ||
average receivables | |||||||
book value per share | -0.85 - | -0.11 86.66% | 2.91 2,678.37% | 2.07 28.74% | 1.02 50.64% | 0.52 49.03% | |
capex per share | |||||||
capex to depreciation | |||||||
capex to operating cash flow | |||||||
capex to revenue | |||||||
cash per share | 0.01 - | 0.00 91.97% | 3.02 528,295.66% | 2.10 30.34% | 1.04 50.38% | 0.54 47.84% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | |||||||
debt to equity | |||||||
dividend yield | |||||||
earnings yield | -0.03 - | -0.06 102.72% | -0.01 90.61% | -0.01 168.39% | -0.04 168.75% | -0.07 69.68% | |
enterprise value | 59.77M - | 59.84M 0.13% | 317.77M 431.00% | 287.73M 9.46% | 182.82M 36.46% | 128.17M 29.89% | |
enterprise value over ebitda | -35.45 - | -17.49 50.66% | -170.83 876.75% | -62.63 63.34% | -22.75 63.68% | -13.74 39.60% | |
ev to operating cash flow | -519.92 - | -204.06 60.75% | -275.62 35.07% | -67.04 75.67% | -29.49 56.02% | -19.78 32.91% | |
ev to sales | |||||||
free cash flow per share | -0.01 - | -0.02 155.12% | -0.12 395.41% | -0.33 173.16% | -0.48 44.81% | -0.50 5.03% | |
free cash flow yield | -0.00 - | -0.00 155.12% | -0.00 32.08% | -0.01 309.45% | -0.03 131.79% | -0.05 51.75% | |
graham net net | -0.85 - | -0.11 86.49% | 2.91 2,639.56% | 2.07 28.73% | 1.02 50.65% | 0.52 49.04% | |
graham number | 1.64 - | 0.85 47.99% | 3.58 320.28% | 4.05 12.96% | 3.68 8.96% | 2.85 22.64% | |
income quality | 0.07 - | 0.09 25.85% | 0.62 622.85% | 0.94 51.72% | 0.79 15.62% | 0.73 8.04% | |
intangibles to total assets | 0.22 - | 0.74 244.36% | 0.00 99.92% | 0.00 18.09% | 0.00 44.13% | 0 100% | |
interest coverage | 37.39 - | ||||||
interest debt per share | -0.02 - | ||||||
inventory turnover | |||||||
invested capital | |||||||
market cap | 59.85M - | 59.85M 0% | 346.43M 478.83% | 314.93M 9.09% | 196.29M 37.67% | 135.16M 31.14% | |
net current asset value | -10.14M - | -1.37M 86.49% | 27.61M 2,115.31% | 26.82M 2.88% | 13.21M 50.76% | 6.70M 49.30% | |
net debt to ebitda | 0.05 - | 0.00 96.04% | 15.41 771,210.32% | 5.92 61.57% | 1.68 71.70% | 0.75 55.29% | |
net income per share | -0.14 - | -0.29 102.72% | -0.20 31.49% | -0.35 79.05% | -0.59 67.90% | -0.69 17.44% | |
operating cash flow per share | -0.01 - | -0.02 155.12% | -0.12 395.41% | -0.33 173.16% | -0.48 44.81% | -0.50 5.03% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -19.85 - | -501.14 2,424.08% | -0.06 99.99% | -0.17 157.04% | -0.57 238.35% | -1.27 124.97% | |
revenue per share | |||||||
roe | 0.17 - | 2.54 1,419.20% | -0.07 102.66% | -0.17 151.25% | -0.58 240.13% | -1.33 130.43% | |
roic | 0.17 - | 2.54 1,419.20% | -0.07 102.66% | -0.17 152.64% | -0.59 247.40% | -1.39 135.26% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | -0.85 - | -0.11 86.66% | 2.91 2,678.37% | 2.07 28.74% | 1.02 50.64% | 0.52 49.03% | |
stock based compensation to revenue | |||||||
tangible asset value | -10.14M - | -1.37M 86.49% | 27.61M 2,115.31% | 26.82M 2.88% | 13.21M 50.76% | 6.70M 49.26% | |
tangible book value per share | -0.85 - | -0.11 86.49% | 2.91 2,639.56% | 2.07 28.73% | 1.02 50.65% | 0.52 49.00% | |
working capital | -643.50K - | -1.37M 112.94% | 27.61M 2,115.31% | 26.82M 2.88% | 13.21M 50.76% | 6.70M 49.30% |
All numbers in USD (except ratios and percentages)